Henry Schein Celebrates the Season of Giving
Henry Schein, Inc. (Nasdaq: HSIC), along with Team Schein Members (TSMs) from around the globe, is once again brightening the holiday season through its 26th annual “Holiday Cheer” program. This…
Category Press Releases
Read MoreHenry Schein Celebrates the Season of Giving
Aptorum Group Reports 2024 Mid-Year Financial Results & Business Update
Aptorum Group Limited (NASDAQ: APM), a clinical-stage biopharmaceutical company focused on addressing unmet medical needs in oncology, autoimmune, and infectious diseases, today released its business update and financial results for…
Vertex Announces FDA Approval of ALYFTREK™ for Cystic Fibrosis Treatment
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) has announced that the U.S. Food and Drug Administration (FDA) has approved ALYFTREK (vanzacaftor/tezacaftor/deutivacaftor), a once-daily, next-generation CFTR (cystic fibrosis transmembrane conductance regulator) modulator. ALYFTREK…
ZIVO Bioscience Reports Early Efficacy of Proprietary Ingredients Against Avian Influenza
ZIVO Bioscience, Inc. (OTCQB: ZIVO), a leading biotech and agtech R&D company focused on developing therapeutic, medicinal, and nutritional products derived from proprietary algal cultures, has announced positive preliminary results…
MedLumics Completes FIM Study, to Present AblaView® PFA Results at AF Symposium 2025
Peter Hinchliffe, CEO of MedLumics, stated, “This marks a key milestone in validating a definitive Atrial Fibrillation (AF) ablation system, utilizing Pulsed Field Ablation (PFA) and Optical Coherence Reflectometry (OCR)…
FlexIt Launches FlexTogether™, Revolutionizing Fitness and Global Connectivity
FlexIt, a leader in virtual fitness and wellness, is excited to announce the launch of FlexTogether™, a groundbreaking platform designed to connect individuals globally through innovative wellness experiences. This new…
Vivani Medical Launches First Human Trial of GLP-1 Implant for Obesity in Australia
Vivani Medical, Inc. (Nasdaq: VANI), an innovative biopharmaceutical company specializing in novel, ultra long-acting drug implants, today announced the initiation of screening and enrollment for its first-in-human clinical trial, LIBERATE-1™,…
COTA and Guardant Health Partner to Advance Precision Oncology with AI and Real-World Data
COTA Inc., a leader in real-world data (RWD) and analytics for oncology, has announced a new partnership with precision oncology company Guardant Health Inc. (Nasdaq: GH). This collaboration will provide…
Noetik Unveils OCTO-VirtualCell and Celleporter: Key Models for Precision Oncology
Noetik, an AI-driven biotech company focused on developing next-generation cancer therapies using self-supervised machine learning and high-throughput spatial data, has announced the release of a technical report on OCTO-VirtualCell (OCTO-vc).…
Mevion Gets Approval for First Compact Proton Therapy System in China
Mevion Medical Systems, a leader in compact proton therapy solutions, has announced that its MEVION S250i Proton Therapy System has received approval from the National Medical Products Administration (NMPA) of…
Life Line Screening Launches ‘Mid-Year Health Check’ for Frequent Health Insights
Life Line Screening, the nation’s top provider of preventive screenings, has introduced its new Mid-Year Health Check Screening. This mid-cycle biometric screening is designed to help individuals track their health…
Health Canada Approves XEOMIN® for Post-Stroke Lower Limb Spasticity Treatment
Merz Therapeutics, part of the Merz Group and a leader in neurotoxin therapies, today announced that Health Canada has approved XEOMIN® (incobotulinumtoxinA) for the treatment of post-stroke lower limb spasticity…